Proven and Experienced Leadership Team
Our team is our foundation. Patients are our inspiration. With decades of experience in the cardiovascular space and years of collaboration, our leadership team is all about efficiency. Our industry and technology experts enable efficient product development, commercialization and acceleration of business milestones.
A proven track record in:
- Engineer novel products
- Execute clinical trials globally
- Regulatory approvals through collaborative approach
- Secure premium reimbursement
- Product commercialization in major markets including the United States, Europe and Japan
President & Chief Executive Officer
Mr. Thatcher has over 35 years of executive and c-level experience in the medical device industry, varying from growing pre-clinical private companies to growing public companies with a market cap of over $1 billion. Prior to 4C Medical, Mr. Thatcher led functional teams in Sales & Marketing, Manufacturing, R&D, Quality, Regulatory, Clinical and Healthcare Policy at Cardiovascular Systems, Inc. In this role, he executed plans to gain product approvals in the U.S. for peripheral and coronary products. His efforts transformed the organization from pre-revenue to one with an annualized revenue of over $200 million and a market cap of over $1.2 billion. Earlier in his career, Mr. Thatcher held positions in commercial management, general management and executive management at Boston Scientific, Schneider and Medtronic where he managed teams throughout the business including Sales, Marketing, Regulatory, Clinical and Reimbursement. He primarily focused on building high performance teams capable of reducing costs and compressing timelines while improving quality and achieving business goals.
Mr. Thatcher earned a Bachelor of Science in Business Administration degree from the University of Florida and a Master of Business Administration degree from Rollins College.
Jeffrey Chambers, MD
Founder, Chief Medical Officer & Chairman of the Board
Dr. Chambers is a national leader in complex coronary interventions and has been in practice for more than 20 years. He is the President of Metropolitan Cardiology Consultants and Director of Research and Cath Lab at Metropolitan Heart and Vascular Institute. Dr. Chambers has a strong background in clinical research and was an investigator in numerous clinical trials in the cardiovascular space. Most notably, he was the national principal investigator for the ORBIT II clinical trial which led to U.S. FDA approval of the Diamondback Coronary Atherectomy System. He is a serial entrepreneur with nine issued patents, some of which are associated with devices commercially available today.
Chief Financial Officer
Mr. Flaherty has an extensive financial management background with more than 30 years of experience. Prior to 4C Medical, his roles included Chief Administrative Officer and Chief Financial Officer at Cardiovascular Systems, Inc., a start-up medical device company which grew to over $1 billion in market valuation, Zomax Incorporated, a publicly traded CD manufacturer which grew revenues from $15 million to over $250 million in fewer than four years, and Racotek, Inc., a start-up wireless data company which became publicly traded. As CFO at these companies, Mr. Flaherty was responsible for all financial matters, information technology, facilities management, legal matters and financial analysis of business development opportunities.
Mr. Flaherty earned a Bachelor of Business Administration in Accounting degree from Loyola University in Chicago.
Katherine (Yekaterina) Kumar, PhD, RAC
Executive Vice President
Dr. Kumar specializes in regulatory and clinical operations as well as science and marketing functional areas of the business. Prior to 4C Medical, she was VP of Clinical and Regulatory Affairs at TVA Medical, Inc., VP of Clinical Affairs at Monteris Medical, Inc. and Sr. Director of Science & Clinical Affairs at Cardiovascular Systems, Inc. (CSI) where she led clinical study development and execution, all scientific activities and the bridge between clinical and marketing activities. Prior to CSI, Dr. Kumar led clinical efforts at MEDRAD Interventional/Possis Medical (a business of Bayer HealthCare), American Medical Systems and several start-up companies.
Dr. Kumar earned her Master of Science and PhD in Mechanical Engineering degrees with honors from the University of North Carolina at Charlotte. She also earned the Regulatory Affairs Certification (RAC) in May 2009 and is Harvard Business School alumni (Executive Education, General Management Program 2017).